HAE
Haemonetics Corp
$90.80
0.42 (0.46%) Today
— up— down
Market Cap
$4.12B+73.5%
Revenue (TTM)
$1.34B+0.4%
Net Income (TTM)
$93.19M-37.4%
EPS (TTM)
2.05-37.4%
Shares Out
45.45M
45.45MP/E Ratio
43.22
43.22Forward P/E
17.11
17.11Open
$90.80
$90.80Previous Close
$90.38
$90.38Day Range
$89.88 – $91.49
$89.88 – $91.4952-Week Range
$47.32 – $92.25
$47.32 – $92.25Beta
0.61
0.61Earnings Date
Nov 4, 2026
Nov 4, 2026Volume
437.33K
437.33KAvg Volume
841.08K
841.08KAnalyst Rating
Buy
BuyExchange
NEW YORK STOCK EXCHANGE, INC.
NEW YORK STOCK EXCHANGE, INC.About HAE
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Related
News
N/AN/AN/AN/A
Haemonetics (HAE) Q1 2027 Earnings Call Transcript
Yahoo · 1d ago
Haemonetics (HAE) Reliance on International Sales: What Investors Need to Know
Yahoo · 3d ago
HAE Q2 Deep Dive: Plasma and Interventional Growth Drive Outperformance, Margin Outlook Steady
Yahoo · 5d ago
Haemonetics Q1 Earnings Call Highlights
Yahoo · 6d ago